Related Experiment Video
Updated: Feb 11, 2026
04:43
Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
Published on: February 27, 2020
7.4K
Recent progress in systemic treatment for lung cancer.
Jeffrey W Clark1, Dan L Longo2
1Harvard Medical School, Massachusetts General Hospital.
Current Opinion in Pulmonary Medicine
|April 27, 2018
Summary
Molecular profiling of lung cancer has advanced treatment. Targeted therapies and immunotherapies show improved effectiveness over traditional chemotherapy for specific patient subgroups.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer treatment has historically relied on chemotherapy.
- Recent advancements focus on understanding the molecular underpinnings of lung cancer.
- Personalized medicine approaches are transforming patient care.
Purpose of the Study:
- To review progress in lung cancer molecular nosology in 2017.
- To discuss the application of new molecular knowledge to lung cancer treatment strategies.
Main Methods:
- Review of recent scientific literature and clinical studies.
- Analysis of data on targeted therapies and immunotherapies.
- Evaluation of molecular profiling techniques for lung cancer diagnosis.
Main Results:
- Targeted agents for specific molecular defects (e.g., EGFR mutations, ALK/ROS1 rearrangements) demonstrate superior efficacy compared to conventional chemotherapy.
- Understanding drug resistance mechanisms has led to improved therapeutic agents and salvage regimens.
- Advances in reversing tumor-induced immunosuppression have enhanced response rates and durable remissions.
Conclusions:
- Tumor molecular analysis is essential for state-of-the-art lung cancer management.
- Treatment decisions should be informed by individual tumor molecular features.
- Future progress lies in combining targeted therapy, immunotherapy, and chemotherapy.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
11.0K
05:11Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
1.9K
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:47Lung Capacity
56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:18Second Order systems II
412
In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
412
01:21First Order Systems
435
First-order systems, such as RC circuits, are foundational in understanding dynamic systems due to their straightforward input-output relationship. Analyzing their responses to different input functions under zero initial conditions reveals significant insights into system behavior.
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
435